Please login or register to print this page.

VIEW TAGS

Articles tagged ‘Eliquis’

May 28, 2015

NOAC news

Apixaban
The National Institute for Health and Care Excellence (NICE) has issued Final Appraisal Determination (FAD) recommending the NOAC (non-vitamin K oral anticoagulant) apixaban (Eliquis®) as an option for the treatment and prevention of recurrent deep vein thrombosis (DVT) and/or pulmonary embolism (PE) in adults.

read more

May 28, 2014

Apixaban can continue during cardioversion

Patients with non valvular atrial fibrillation (NVAF) should remain on apixaban while undergoing cardioversion, according to a recommendation from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP).1

read more

October 30, 2013

Assay for apixaban plasma concentration

An assay for measuring the circulating blood concentration of the oral Factor Xa inhibitor apixaban is being developed in a joint research agreement between Bristol-Myers Squibb and Diagnostica Stago S.A.S, a privately held company that provides reference tests and instrumentation in haemostasis. No commercial assay is presently available to specifically measure apixaban plasma concentration. The terms of the agreement were not disclosed.

read more

Members Area

Log in or Register now.

SEARCH THE SITE

RSS FEED

Subscribe to our RSS feed
home

GET EXCLUSIVE UPDATES

Sign up for our regular email newsletters & be the first to know about fresh articles and site updates.

RECENT COMMENTS

    None Found

ENDORSED BY

  • ArrhythmiaAlliance
  • Stars
  • Anticoagulation Europe
  • Atrial Fibrillation Association
 

You are not logged in

You need to be a member to print this page.
Sign up for free membership, or log in.

You are not logged in

You need to be a member to download PDF's.
Sign up for free membership, or log in.